Karine Bouhier‐Leporrier

Statistics

Publications

Citations

4.4K

H-Index

Active since

2011

Affiliations

Centre Hospitalier Universitaire de Caen Normandie(Current)

Inserm

Université de Caen Normandie

Centre François Baclesse

Assistance Publique – Hôpitaux de Paris

Karine Bouhier‐Leporrier is an author at Centre Hospitalier Universitaire de Caen Normandie specializing in oncology, medicine, and gastrointestinal oncology.

Publications per year

2011–2023

Publications

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +14

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

Julien Edeline, M. Benabdelghani, Aurélie Bertaut et al. · Journal of Clinical Oncology · 2019 · 529 citations

Medicine, Oncology, Surgery +11

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez et al. · JAMA Oncology · 2022 · 324 citations · Full text

Medicine, Oncology, Surgery +14

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

Thomas Walter, David Tougeron, Éric Baudin et al. · European Journal of Cancer · 2017 · 112 citations

Medicine, Oncology, Pathology +14

Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.

Julien Edeline, Franck Bonnetain, Jean–Marc Phelip et al. · Journal of Clinical Oncology · 2017 · 110 citations

Medicine, Oncology, Surgery +12

1–5 of 21